Monitor for a follow-on pricing press release or prospectus supplement. At-the-market or block offerings could weigh on SLNO shares. Given the bearish consensus and pre-revenue status, any near-term equity raise would likely be dilutive.
Price Chart
How similar events traded
Executive Summary
Soleno Therapeutics' shelf registration statement on Form S-3 (File No. 333-275120) was declared effective by the SEC on May 27, 2026. This allows the company to offer and sell up to an undisclosed amount of securities from time to time, creating a potential near-term dilution overhang for existing shareholders.
Key Facts
- Form S-3 shelf registration (File No. 333-275120) became effective on May 27, 2026
- Company can now sell shares, debt, or other securities at its discretion over time
- Pre-revenue clinical-stage biotech with 80% analyst Hold/Sell/Strong Sell consensus (0% bullish)
Financial Impact
Undisclosed, shelf registration allows flexible capital raising; no specific offering size or pricing disclosed
Risk Factors
- Imminent equity offering could dilute existing shareholders materially
- No cash runway or burn rate disclosed, with no approved products, capital needs are likely
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-001764 |
| Document: 9999999995-26-001764-index.html | 9999999995-26-001764 |
| Document: 9999999995-26-001764.txt | 9999999995-26-001764 |
Track record
10 reports on SLNO
2 of 3 bullish or bearish reports moved the stock their way by T+5. Best: +2.57% at T+1 after the Feb 26, 2026 report. 2 of 4 went positive at some point.
Filters
- Jun 11, 202622w ago Institutional Cluster Bullish 6/10 No price data
- Jun 11, 202622w ago Institutional Cluster Mixed 4/10 No price data
- May 28, 202624w ago 15-12G Bearish 8/10 No price data
- May 28, 202624w ago EFFECT Bearish 5/10 Viewing No price data
- May 18, 202626w ago 8-K / 25-NSE Bullish 8/10 Entry $53.01 No price data
- Apr 7, 202631w ago 8-K Bearish 7/10 Entry $52.35 to $52.62 ▼ −0.52% +4.81% vs SPY
- Apr 6, 202632w ago 8-K Bullish 8/10 Entry $52.25 to $52.64 ▲ +0.75% −3.39% vs SPY
- Mar 27, 202633w ago Insider Cluster Neutral 3/10 Entry $30.05 to $52.25 ▲ +73.88% +70.01% vs SPY
- Feb 26, 202637w ago 8-K Bullish 8/10 Entry $38.09 to $38.57 ▲ +1.26% +2.42% vs SPY
- Feb 26, 202637w ago 8-K Neutral 3/10 Entry $38.09 to $38.57 ▲ +1.26% +2.39% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers